Surgery in recurrent ovarian cancer

Area of Science:

• Gynecologic Oncology
• Surgical Oncology

Background:

• Ovarian cancer frequently recurs, necessitating advanced therapy standards.
• Postoperative residual tumor mass is a critical prognostic factor in primary ovarian cancer.
• Surgical management of recurrent ovarian cancer remains a debated topic with limited prospective data.

Purpose of the Study:

• To review the current evidence on the impact of surgery for recurrent ovarian cancer.
• To highlight the importance of patient selection for cytoreductive surgery in recurrent disease.
• To identify research gaps in establishing operative standards for recurrent ovarian cancer.

Main Methods:

• Review of published prospective clinical trials on surgery for relapsed ovarian cancer.
• Analysis of prognostic factors, particularly residual tumor after surgery.
• Discussion of the challenges in patient selection for complete tumor resection.

Main Results:

• Complete cytoreduction in recurrent ovarian cancer is associated with improved prognosis.
• Identifying patients who will benefit from complete tumor resection is essential but challenging.
• Reliable predictive factors for successful resection are still under investigation.

Conclusions:

• Surgery, specifically complete cytoreduction, offers prognostic benefits for recurrent ovarian cancer.
• Further research is crucial to define predictive factors and patient selection criteria for surgery.
• Randomized trials are needed to establish operative standards for recurrent ovarian cancer management.